The authors assessed data from 1,148 outpatients in a 10-week medical symptom reduction program to determine the effectiveness of a behavioral medicine intervention among somatizing patients. The program included instruction in the relaxation response, cognitive restructuring, nutrition, and exercise. Before and after the intervention, the patients were evaluated on the Symptom Checklist-90 Revised (SCL-90R), the Medical Symptom Checklist, and the Stress Perception Scale. They were divided into high- and low-somatizing groups on the basis of the pretreatment SCL-90R somatization scale. At the end of the program, physical and psychological symptoms on the Medical Symptom Checklist and the SCL-90R were significantly reduced in both groups, with the reductions greater in the high-somatizing group. Improvements in stress perception were about the same in both groups, but the absence of an untreated control group precluded estimates of how much the improvements resulted from the behavioral medicine intervention and how much from natural healing over time.
Somatization and symptom reduction through a behavioral medicine intervention in a mind/body medicine clinic
Publication
Behavioral Medicine
Volume 26, Issue 4
Abstract
Web and Email Links
Related Listings
Journal
Journal of American College Health
·
The authors examined the effect of a 6-week mind/body intervention on college students' psychological distress, anxiety, and perception of stress. One hundred twenty-eight students were randomly assigned to an experimental group (n = 63) or a waitlist control group (n = 65). The experimental group received 6 90-minute group-training sessions in the relaxation response and cognitive behavioral skills. The Symptom Checklist-90-Revised, Spielberger State-Trait Anxiety Inventory, and the […]
Journal
Yoga Alliance
About This Workshop 70-90% of all primary care visits in America are related to chronic stress and stress-related illnesses such as anxiety, depression, PTS, heart disease, headaches, GI disruptions, and more. In the next workshop of the Scientific Research series, Yoga Alliance Director of Research, Dr. Sat Bir Singh Khalsa is joined by Dr. John Denninger, Director of Research at the Benson-Henry Institute for Mind Body Medicine at Massachusetts General Hospital and Harvard Universit […]
Journal
Frontiers in Psychiatry
Background: Obsessive-compulsive disorder (OCD) is often a life-long disorder with high psychosocial impairment. Serotonin reuptake inhibitors (SRIs) are the only FDA approved drugs, and approximately 50% of patients are non-responders when using a criterion of 25% to 35% improvement with the Yale-Brown Obsessive-Compulsive Scale (Y-BOCS). About 30% are non-responders to combined first-line therapies (SRIs and exposure and response prevention). Previous research (one open, one randomi […]